Janardan Khandekar to Male
This is a "connection" page, showing publications Janardan Khandekar has written about Male.
Connection Strength
0.140
-
APC gene testing for familial adenomatosis polyposis. JAMA. 2012 Aug 01; 308(5):514-5.
Score: 0.020
-
Biomarkers for the early detection of cancer: an inflammatory concept. Arch Intern Med. 2007 Sep 24; 167(17):1822-4.
Score: 0.014
-
Phase 1 clinical trials: not just for safety anymore? Arch Intern Med. 2006 Jul 24; 166(14):1440-1.
Score: 0.013
-
Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample. PLoS One. 2021; 16(10):e0258970.
Score: 0.009
-
Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the United Kingdom Biobank. Am J Trop Med Hyg. 2021 Jun 15; 105(2):368-371.
Score: 0.009
-
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). Cancer. 2017 Dec 01; 123(23):4653-4662.
Score: 0.007
-
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. Eur Urol. 2017 05; 71(5):740-747.
Score: 0.007
-
Promotion of self-management for post treatment cancer survivors: evaluation of a risk-adapted visit. J Cancer Surviv. 2016 Feb; 10(1):206-19.
Score: 0.006
-
Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol. 1995 Mar; 2(2):160-4.
Score: 0.006
-
Extragonadal seminoma involving urinary bladder and arising in the prostate. Cancer. 1993 Jun 15; 71(12):3972-4.
Score: 0.005
-
Effect of cardiopulmonary bypass on tissue injury markers and endothelial activation during coronary artery bypass graft surgery. J Postgrad Med. 2012 Jan-Mar; 58(1):8-13.
Score: 0.005
-
Changes in performance after implementation of a multifaceted electronic-health-record-based quality improvement system. Med Care. 2011 Feb; 49(2):117-25.
Score: 0.004
-
Complete response of metastatic basal cell carcinoma to cisplatin chemotherapy: a report on two patients. Arch Dermatol. 1990 Dec; 126(12):1660.
Score: 0.004
-
Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma. Cancer Invest. 2007 Aug; 25(5):366-71.
Score: 0.004
-
Phase II study of cisplatin for metastatic prostatic carcinoma. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1983 Apr; 6(2):203-5.
Score: 0.003
-
Causes and evaluation of tumor-induced hypoglycemia. Arch Surg. 1982 Jul; 117(7):905-8.
Score: 0.002
-
Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study. Cancer Treat Rep. 1982 Feb; 66(2):405-6.
Score: 0.002
-
Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885. Am J Clin Oncol. 2001 Apr; 24(2):150-4.
Score: 0.002
-
Neurologic involvement in glucagonoma syndrome: response to combination chemotherapy with 5-fluorouracil and streptozotocin. Cancer. 1979 Dec; 44(6):2014-6.
Score: 0.002
-
A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatments. Cancer. 1979 Sep; 44(3):824-30.
Score: 0.002
-
Paclitaxel as the initial treatment of multiple myeloma: an Eastern Cooperative Oncology Group Study (E1A93). Am J Clin Oncol. 1998 Dec; 21(6):553-6.
Score: 0.002
-
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium. Int J Radiat Oncol Biol Phys. 1996 Mar 01; 34(4):793-802.
Score: 0.002
-
High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial. Invest New Drugs. 1994; 12(4):299-301.
Score: 0.001
-
A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract. Cancer. 1989 Dec 15; 64(12):2445-7.
Score: 0.001
-
Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial. Cancer Treat Rep. 1987 Jun; 71(6):649-50.
Score: 0.001
-
Thyroid hormone administration in irradiated patients. J Surg Oncol. 1986 Mar; 31(3):214-7.
Score: 0.001
-
Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial. Cancer Treat Rep. 1986 Feb; 70(2):307-8.
Score: 0.001
-
A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer. 1985 Aug 01; 56(3):457-60.
Score: 0.001
-
A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Cancer Res. 1985 Feb; 45(2):863-71.
Score: 0.001
-
Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial. Cancer Treat Rep. 1984 Oct; 68(10):1303-4.
Score: 0.001
-
Effect of interferon therapy on indomethacin-sensitive immunoregulation in the peripheral blood mononuclear cells of renal cell carcinoma patients. J Biol Response Mod. 1983; 2(3):251-62.
Score: 0.001
-
Urinary bladder metastases from breast carcinoma. Cancer. 1980 Jul 01; 46(1):229-32.
Score: 0.001
-
Metastatic basal cell carcinoma. J Surg Oncol. 1980; 15(2):171-80.
Score: 0.001
-
Preoperative physical assessment of thyroid glands in previously irradiated patients. Am J Surg. 1979 Nov; 138(5):666-7.
Score: 0.001